Clinical Trial Imaging Services Market, valued at USD 1.31 billion in 2023, is expected to grow at a compound annual growth rate of 5.4 ...

Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant high-grade serous ...

Records reveal that last year, police in Massachusetts cited more than 432 drivers age 90 and older for motor vehicle violations. That includes 91 seniors given citations after crashes.

I’m thrilled to join the NUCATS team and become part of an Institute with such broad reach,” says Bucek. “The opportunity to ...

FAP is a pan-cancer marker expressed in the tumor microenvironment of epithelial cancers and on the surface of some specific cancer types, including sarcomas and mesotheliomas.

Mass General Brigham, Emory and other providers will assess different AI models from companies like Google, Microsoft and ...

Presented positive ReSPECT-GBM Phase 1/2 Trial update data at the 2024 Congress of Neurological Surgeons Annual Conference, ...

Annual BioTech Breakthrough Award is devoted to honoring excellence in life science and biotechnology solutions, services, ...

Merck & Co (MSD), Alexion, and AstraZeneca Rare Disease have reported positive topline outcomes from the Phase III KOMET ...

Q3 2024 Earnings Call Transcript November 15, 2024 Operator: Hello, and welcome to the AIM ImmunoTech Third Quarter 2024 ...

Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024 New CM24 biomarkers data presented during the third quarter of 2024 including two predicting serum biomarkers identif ...

The study highlighted clinical inertia in adopting new HF therapies ... to their peers (AF arm), and 30 received this ...